Paul Silva - Vertex Pharmaceuticals Insider

VRTX -- USA Stock  

USD 175.80  3.21  1.79%

Mr. Paul M. Silva is Senior Vice President and Corporationrationrate Controller of Vertex Pharmaceuticals Incorporated. Mr. Silva is our Senior Vice President and Corporationrationrate Controller, a position he has held since April 2011. Mr. Silva joined us in August 2007 as Senior Director, Accounting Operations and was our Vice President and Corporationrationrate Controller from September 2008 through April 2011. Prior to joining us, he was the Vice President, Internal Reporting at Iron Mountain Incorporated from July 2006 until August 2007 and a consultant to Iron Mountains financing department from April 2005 until July 2006. He was the Finance Director of the Bioscience Technologies Division of Thermo Electron Corporationrationration from 2002 to April 2005
Age: 50  President Since 2011      
Silva holds a B.S. in accounting from Assumption College.

Paul Silva Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 8.49 % which means that it generated profit of $8.49 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 10.67 % meaning that it created $10.67 on every $100 dollars invested by stockholders.
The company currently holds 592.73 M in liabilities with Debt to Equity (D/E) ratio of 21.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Vertex Pharmaceuticals Incorporated has Current Ratio of 3.6 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives


Andrew FentonZoetis
Joseph LaRosaRegeneron Pharmaceuticals
Peter PowchikRegeneron Pharmaceuticals
Robert LechleiderSeattle Genetics
Douglas McCorkleRegeneron Pharmaceuticals
Alejandro BernalZoetis
Marion McCourtRegeneron Pharmaceuticals
Raghav ChariDr Reddys Laboratories Limited
Amit BiswasDr Reddys Laboratories Limited
Sripada ChandrasekharDr Reddys Laboratories Limited
Alok SonigDr Reddys Laboratories Limited
Cartikeya ReddyDr Reddys Laboratories Limited
Daniel PlewRegeneron Pharmaceuticals
Kristin PeckZoetis
Joyce LeeZoetis
Clinton LewisZoetis
Ganadhish KamatDr Reddys Laboratories Limited
Samiran DasDr Reddys Laboratories Limited
Roxanne LaganoZoetis
Catherine KnuppZoetis
Sandra BeatyZoetis

Entity Summary

Vertex Pharmaceuticals Incorporated, a biotechnology company, develops medicines for serious diseases. The company was founded in 1989 and is headquartered in Boston, Massachusetts. Vertex Pharmaceuticals operates under Biotechnology classification in USA and traded on NASDAQ. It employs 2300 people.Vertex Pharmaceuticals Incorporated (VRTX) is traded on NASDAQ in USA. It is located in 50 Northern Avenue and employs 2,300 people.

Vertex Pharmaceuticals Leadership Team

Paul Silva, Senior Vice President Corporate Controller
William Young, Independent Director
David Altshuler, Independent Director
Reshma Kewalramani, Executive Vice President - Global Medicines Development and Medical Affairs and Chief Medical Officer
Jeffrey Chodakewitz, Chief Medical Officer and Senior Vice President - Global Medicines Development
Elaine Ullian, Co-Lead Independent Director
Michael Parini, Executive Vice President and Chief Legal Officer
Alan Garber, Independent Director
Amit Sachdev, Senior Vice President - Global Government Strategy, Market Access and Value
Joshua Boger, Executive Director and Chairman of Science and Technology Committee
David Greenway, Director
Bruce Sachs, Co-Lead Independent Director
Margaret McGlynn, Independent Director
Michael Partridge, Vice President - Investor Relations
Yuchun Lee, Independent Director
Sangeeta Bhatia, Director
Kimberly White, Senior Vice President and Chief Communications Officer
Stuart Arbuckle, Chief Commercial Officer and Executive VP
Thomas Graney, CFO, Senior Vice President
Terrence Kearney, Independent Director
Ian Smith, CFO, Executive Vice President
Jeffrey Leiden, Chairman of the Board and Presidentident, CEO

Stock Performance Indicators

Did you try this?

Run Equity Search Now


Equity Search

Search for activelly-traded equities including funds and ETFs from over 30 global markets
All  Next Launch Equity Search

Also Currentnly Active

Purchased over 70 shares of
few hours ago
Traded for 35.02
Purchased a lot of shares of
few hours ago
Traded for 154.92
Purchased over 20 shares of
few hours ago
Traded for 112.14
Also please take a look at World Market Map. Please also try Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.